Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection.
Guin, S.; montoya, m.; wang, X.; Zarnowski, R.; Andes, D. R.; Meyers, M. J.; Williams, N.; Krysan, D. J.
Show abstract
Only three classes of antifungal drugs are currently in clinical use. Here, we report that derivatives of the malarial drug mefloquine have broad spectrum antifungal activity including difficult to treat molds and endemic fungi. Pharmacokinetic and efficacy studies of NSC-4377 indicate it penetrates the central nervous system and is active against Candida auris in vivo. These data strongly support the further development of mefloquine analogs as a potentially new class of antifungal molecules.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Fenbendazole controls in vitro growth, virulence potential and animal infection in the Cryptococcusmodel 94%
- Strongly bactericidal all-oral β-lactam combinations for the treatment of Mycobacterium abscessus lung disease 94%
- Effective Therapy Targeting Cytochrome bc1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection 93%
Similar papers in this journal
- Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformans 96%
- Discovery of fungal-specific targets and inhibitors using chemical phenotyping of pathogenic spore germination 95%
- Inhibitors of trehalose-6-phosphate synthase activity in fungal pathogens compromise thermal tolerance pathways 93%
Similar papers in this journal
- Pentamidine inhibition of streptopain attenuates Streptococcus pyogenes virulence 93%
- Natural products lysobactin and sorangicin A show in vitro activity against Mycobacterium abscessus complex 91%
- Differential growth rates and in vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri 90%
Similar papers in this journal
- Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi 92%
- Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2 91%
- Small-Molecule In Vitro Inhibitors of the Coronavirus Spike - ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2 90%
Similar papers in this journal
- Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds 93%
- A Nanoemulsion as an Effective Treatment Against Human Pathogenic Fungi 92%
- Functional characterization of clinical isolates of the opportunistic fungal pathogen Aspergillus nidulans 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.